✕
Accure Therapeutics is one of the excellent companies that are part of ELITE, the pan-European ecosystem of the Euronext Group that helps small and medium-sized enterprises grow and access private and public capital markets.
Join the ELITE NetworkDescription
Accure Therapeutics is a private translational neuroscience R&D company Based in Barcelona (it was launched in 2020 with a Series A funding led by Alta Life Sciences Spain I and supported by the Centre for Technological and Industrial Development). This European company with an international mindset boasts a unique portfolio of three new chemical entity programs pursuing innovative targets with potential to accommodate others. Accure aims to develop new disease modifying drugs to treat serious conditions such as optic neuritis, multiple sclerosis, ParkinsonParkinson’s disease and epilepsy. With an experienced business and scientific team, Accure Therapeutics is one of the few companies that operate in an agnostic fashion on initial science to deliver cutting edge drugs in CNS. To learn more visit https://accure.health/
Business Information
COUNTRY
Spain
Members
Shareholders
Business Description